Zealand Pharma A-S News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.12.23	Total number of shares and voting rights in Zealand Pharma at December 29, 2023 (GlobeNewswire)
23.12.23	U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing (GlobeNewswire)
07.12.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
07.12.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
04.12.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
30.11.23	Total number of shares and voting rights in Zealand Pharma at November 30, 2023 (GlobeNewswire)
30.11.23	Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers (GlobeNewswire)
16.11.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
09.11.23	Zealand Pharma Announces Financial Results for the First Nine Months of 2023 (GlobeNewswire)
20.10.23	Zealand Pharma major shareholder announcement: Polar Capital (GlobeNewswire)
29.09.23	Total number of shares and voting rights in Zealand Pharma at September 29, 2023 (GlobeNewswire)
14.09.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
14.09.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
31.08.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
31.08.23	Total number of shares and voting rights in Zealand Pharma at August 31, 2023 (GlobeNewswire)
30.08.23	Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism (GlobeNewswire)
25.08.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
24.08.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
17.08.23	Zealand Pharma Announces Financial Results for the First Half of 2023 (GlobeNewswire)
03.07.23	Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 (GlobeNewswire)
30.06.23	Total number of shares and voting rights in Zealand Pharma at June 30, 2023 (GlobeNewswire)
08.06.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
31.05.23	Total number of shares and voting rights in Zealand Pharma at May 31, 2023 (GlobeNewswire)
25.05.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
23.05.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
12.05.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
11.05.23	Zealand Pharma Announces Financial Results for the First Quarter of 2023 (GlobeNewswire)
10.05.23	Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight (GlobeNewswire)
28.04.23	Total number of shares and voting rights in Zealand Pharma at April 28, 2023 (GlobeNewswire)
25.04.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
19.04.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
19.04.23	Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 (GlobeNewswire)
04.04.23	Zealand Pharma completes registration of capital increase (GlobeNewswire)
03.04.23	Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen (GlobeNewswire)
31.03.23	Total number of shares and voting rights in Zealand Pharma at March 31, 2023 (GlobeNewswire)
30.03.23	Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion (GlobeNewswire)
30.03.23	Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares (GlobeNewswire)
28.03.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
28.03.23	Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396 (GlobeNewswire)
13.03.23	Zealand Pharma Provides Update on Silicon Valley Bank Closure (GlobeNewswire)
12.03.23	Zealand Pharma Provides Statement on Silicon Valley Bank Closure (GlobeNewswire)
10.03.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
09.03.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
02.03.23	Zealand Pharma convenes its Annual General Meeting 2023 (GlobeNewswire)
02.03.23	Zealand Pharma Announces Full Year Results for 2022 (GlobeNewswire)
17.11.22	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
17.11.22	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
08.11.22	Zealand Pharma to Participate in Upcoming Investor Conferences (GlobeNewswire)
03.11.22	Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022 (GlobeNewswire)
31.10.22	Total number of shares and voting rights in Zealand Pharma at October 31, 2022 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Zealand Pharma A-S

Aktien Top/Flop

Meistgelesene Nachrichten